Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Mental Health (no longer under consideration since Apr 28, 2021)

Date Submitted: Apr 27, 2021

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Can Salt Valproate Prevent Switch Associated With Antidepressants in Depressive Patients?Meta-analysis From Chinese Data

  • Shen Dong; 
  • Wangqiang Lv; 
  • Fengli Sun; 
  • Weidong Jin

ABSTRACT

Background:

There are many ways to strengthen the effects of treatment for depressive patients,in which, add on mood stabilizer is one of these many ways. And at same time,it was very common that antidepressant induce switch to mania.Does the mood stabilizer can prevent the switch?This study is that assessment the difference between combination treatment of valproate and antidepressant and monotherapy antidepressant.

Objective:

to assess the preventing switch effect of valproate in depressive patients treated by antidepressant

Methods:

We searched Chinese Biomedical Database(CBM), China National Knowledge Infrastructure(CNKI) , WANFANG database,and Chinese Social Sciences Citation Index(CSSCI) in Chinese to find literature from 1 January 2005 to 1 January 2020 related to the study in model of “comparison of switch rate between combination treatment of valproate and antidepressant and monotherapy of antidepressant in depressive patients” ,among which results such as comments, letters, reviews and case reports were excluded. The rate of switch between groups was synthesized and discussed.

Results:

A total of 549 subjects were included in 7 studies,in which in 279 cases are in combination group and 270 cases are in group of monotherapy by antidepressant . Random effect model is used to account for the data by Revman 5.2. The results showed that the switch rate of valproate group was 0.11%(3/279),switch rate of antidepressant group was 11.11%( 30/270), which was very different in switch rate(OR=0.13 ,95% CI: 0.05–0.35) and also indicated that valproate reduced switch rate was 99%[ (11.11%-0.11%)/11.11%]. In sodium valproate group, switch rate was 0%,while switch rate in antidepressant was 5.7%( OR=0.18,95%CI=0.04-0.84),which was significantly different(Z=2.18,P=0.03). In magnesium valproate group, switch rate was 2.2%,while switch rate in antidepressant was16.92%( OR=0.11,95%CI=0.03-0.39),which was significantly different(Z=3.47,P=0.0005).

Conclusions:

The salt valproate can reduced switch rate related to antidepressant in depressive patients. In this study, salt valproate reduce 99% switch rate. Clinical Trial: NO


 Citation

Please cite as:

Dong S, Lv W, Sun F, Jin W

Can Salt Valproate Prevent Switch Associated With Antidepressants in Depressive Patients?Meta-analysis From Chinese Data

JMIR Preprints. 27/04/2021:29991

DOI: 10.2196/preprints.29991

URL: https://preprints.jmir.org/preprint/29991

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.